EGALET LTD.
22Patents
21Active
22Granted
49Portfolio score
Filing activity: Mar 26, 2004 → Oct 14, 2016 · 7 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8609143B2 | Morphine polymer release system | Human Necessities | 44 | Active |
| US8617605B2 | Polymer release system | Human Necessities | 19 | Active |
| US8603526B2 | Pharmaceutical compositions resistant to abuse | Human Necessities | 18 | Active |
| US8877241B2 | Morphine controlled release system | Human Necessities | 17 | Active |
| US7883722B2 | Controlled release composition | Human Necessities | 16 | Expired |
| US8563038B2 | Formulations and methods for the controlled release of active drug substances | Human Necessities | 15 | Active |
| US9044402B2 | Abuse-deterrent pharmaceutical compositions for controlled release | Human Necessities | 14 | Active |
| US8821928B2 | Controlled release pharmaceutical compositions for prolonged effect | Human Necessities | 14 | Active |
| US9168228B2 | Pharmaceutical compositions resistant to abuse | Human Necessities | 13 | Active |
| US8449914B2 | Controlled release carvedilol compositions | Human Necessities | 11 | Active |
| US8808745B2 | Morphine polymer release system | Human Necessities | 9 | Active |
| US9005660B2 | Immediate release composition resistant to abuse by intake of alcohol | Human Necessities | 8 | Active |
| US9642809B2 | Controlled release pharmaceutical compositions for prolonged effect | Human Necessities | 6 | Active |
| US9358295B2 | Immediate release composition resistant to abuse by intake of alcohol | Human Necessities | 6 | Active |
| US9023394B2 | Formulations and methods for the controlled release of active drug substances | Human Necessities | 5 | Active |
| US9375428B2 | Morphine controlled release system | Human Necessities | 3 | Active |
| US9498446B2 | Pharmaceutical compositions resistant to abuse | Human Necessities | 1 | Active |
| US9694080B2 | Polymer release system | Human Necessities | 0 | Active |
| US10105321B2 | Pharmaceutical compositions resistant to abuse | Human Necessities | 0 | Active |
| US9549899B2 | Abuse deterrent pharmaceutical compositions for controlled release | Human Necessities | 0 | Active |
| US9707179B2 | Opioid polymer release system | Human Necessities | 0 | Active |
| US9884029B2 | Morphine controlled release system | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.